A Randomized, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of a Single Dose Regimen of Live Attenuated Oral Cholera Vaccine (CholeraGarde) in HIV-Seropositive Adults in Thailand
Phase of Trial: Phase II
Latest Information Update: 19 Feb 2016
At a glance
- Drugs Cholera vaccine live attenuated (Primary)
- Indications Cholera
- Focus Adverse reactions
- 29 Mar 2012 Actual end date (Jun 2011) added as reported by ClinicalTrials.gov.
- 29 Mar 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 20 May 2011 Planned end date changed from 1 Jan 2011 to 1 Sep 2011 as reported by ClinicalTrials.gov.